Katharine A. Price, MD

Articles by Katharine A. Price, MD

Dr Price on the Potential Role for HPV-Targeted Immunotherapy Vaccines in HPV+ HNSCC

September 12th 2024

Katharine A. Price, MD, discusses the potential role for injectable HPV-targeted immunotherapy vaccines in HPV16-positive head and neck squamous cell carcinoma.

Mayo Clinic Physicians Seek to Address Bias in Medical Education

ByKatharine A. Price, MD,Rahma Warsame, MD

July 13th 2022

The clinical learning environment for medical trainees is the foundation of medical training programs.

Katharine A. Price, MD

Articles by Katharine A. Price, MD

Dr Price on the Potential Role for HPV-Targeted Immunotherapy Vaccines in HPV+ HNSCC

Mayo Clinic Physicians Seek to Address Bias in Medical Education

Latest Updated Articles

Trending on OncLive

Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma

FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL

Real-World Data Support Clinical Benefit With Lifileucel in Previously Treated Advanced Melanoma

Single-Center, Retrospective Data Show Low Rate of Lifileucel Infusion Following Referral in Advanced Melanoma

Dr Riedell on the Long-Term Efficacy of Tisa-Cel in R/R Follicular Lymphoma